The National Pharmaceutical Pricing Authority (NPPA) on Thursday assured that there is sufficient stock of raw materials for medicines and formulations available to meet requirements of the situation arising due to the coronavirus outbreak.
NPPA Chairman Shubhra Singh met representatives of pharmaceutical industry associations on the issue of availability of critical active pharmaceutical ingredients (APIs).
"Chairman NPPA met today representatives of the Pharma Associations on the issue of availability of critical APIs. It is assured that sufficient stock of critical APIs and formulations is available to meet the requirements of the situation arising out of COVID-19," the drug pricing authority said in a tweet.
It further said, "Indian Drug Manufacturers' Association (IDMA) has assured NPPA regarding enough stock of APIs and formulations. No shortages in the near future."
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app